Arkema Sa Adr Stock Price To Earnings To Growth
| ARKAY Stock | USD 79.24 1.06 1.36% |
Arkema SA ADR fundamentals help investors to digest information that contributes to Arkema SA's financial success or failures. It also enables traders to predict the movement of Arkema Pink Sheet. The fundamental analysis module provides a way to measure Arkema SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arkema SA pink sheet.
Arkema |
Arkema SA ADR Company Price To Earnings To Growth Analysis
Arkema SA's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Arkema SA Price To Earnings To Growth | 0.77 X |
Most of Arkema SA's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arkema SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Arkema SA ADR has a Price To Earnings To Growth of 0.7702 times. This is 31.23% lower than that of the Basic Materials sector and 27.34% lower than that of the Specialty Chemicals industry. The price to earnings to growth for all United States stocks is 84.25% higher than that of the company.
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Arkema Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0333 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.73 B | |||
| Shares Outstanding | 74.81 M | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | 18.63 X | |||
| Price To Book | 0.82 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 9.52 B | |||
| Gross Profit | 2.14 B | |||
| EBITDA | 2.54 B | |||
| Net Income | 1.31 B | |||
| Cash And Equivalents | 1.34 B | |||
| Cash Per Share | 18.14 X | |||
| Total Debt | 2.56 B | |||
| Debt To Equity | 0.47 % | |||
| Current Ratio | 1.90 X | |||
| Book Value Per Share | 105.12 X | |||
| Cash Flow From Operations | 915 M | |||
| Earnings Per Share | 15.24 X | |||
| Price To Earnings To Growth | 0.77 X | |||
| Target Price | 110.28 | |||
| Number Of Employees | 20.2 K | |||
| Beta | 1.27 | |||
| Market Capitalization | 7.51 B | |||
| Total Asset | 12.3 B | |||
| Retained Earnings | 1.21 B | |||
| Working Capital | 1.92 B | |||
| Current Asset | 3.4 B | |||
| Current Liabilities | 1.48 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.57 % | |||
| Net Asset | 12.3 B | |||
| Last Dividend Paid | 3.0 |
About Arkema SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arkema SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arkema SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arkema SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Arkema Pink Sheet Analysis
When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.